Caveolin-1 overexpression in benign and malignant salivary gland tumors

[1]  C. Keller,et al.  Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma , 2015, Laboratory Investigation.

[2]  D. Turner,et al.  Caveolin‐1 enhances rapid mucosal restitution by activating TRPC1‐mediated Ca2+ signaling , 2014, Physiological reports.

[3]  Wen-Chao Liu,et al.  Caveolin-1 Limits the Contribution of BKCa Channel to MCF-7 Breast Cancer Cell Proliferation and Invasion , 2014, International journal of molecular sciences.

[4]  F. Persson,et al.  Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers. , 2014, Oral oncology.

[5]  S. Pardis,et al.  Caveolin-1 Expression in Odontogenic Cysts and Ameloblastomas , 2014, Turk patoloji dergisi.

[6]  S. Pardis,et al.  MCM3 as a novel diagnostic marker in benign and malignant salivary gland tumors. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[7]  M. Moshaverinia,et al.  Salivary gland tumors: a clinicopathologic study of 366 cases in southern Iran. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[8]  D. Cai,et al.  Inverse Correlation between Caveolin-1 Expression and Clinical Severity in Psoriasis Vulgaris , 2012, The Journal of international medical research.

[9]  T. Nagao,et al.  Immunohistochemical Analysis of Salivary Gland Tumors: Application for Surgical Pathology Practice , 2012, Acta histochemica et cytochemica.

[10]  Huafei Zou,et al.  Interaction of Caveolin-1 with Ku70 Inhibits Bax-Mediated Apoptosis , 2012, PloS one.

[11]  J. M. Ryu,et al.  Involvement of caveolin‐1 in fibronectin‐induced mouse embryonic stem cell proliferation: Role of FAK, RhoA, PI3K/Akt, and ERK 1/2 pathways , 2011, Journal of cellular physiology.

[12]  S. Hehlgans,et al.  Caveolin-1: an essential modulator of cancer cell radio-and chemoresistance. , 2011, American journal of cancer research.

[13]  I. Nabi,et al.  Lipid rafts, caveolae, and their endocytosis. , 2010, International review of cell and molecular biology.

[14]  F. Sotgia,et al.  An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers. , 2009, The American journal of pathology.

[15]  C. Restall,et al.  Stromal cell expression of caveolin-1 predicts outcome in breast cancer. , 2009, The American journal of pathology.

[16]  Jia-hong Dong,et al.  Overexpression of Caveolin-1 in Hepatocellular Carcinoma with Metastasis and Worse Prognosis: Correlation with Vascular Endothelial Growth Factor, Microvessel Density and Unpaired Artery , 2009, Pathology & Oncology Research.

[17]  O. Sagol,et al.  Differential expression of Caveolin-1 in hepatocellular carcinoma: correlation with differentiation state, motility and invasion , 2009, BMC Cancer.

[18]  S. Dima,et al.  Caveolin-1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma , 2009, Journal of Molecular Histology.

[19]  S. Wiseman,et al.  Caveolin-1 in tumor progression: the good, the bad and the ugly , 2008, Cancer and Metastasis Reviews.

[20]  T. Timme,et al.  Mice with cav-1 gene disruption have benign stromal lesions and compromised epithelial differentiation. , 2008, Experimental and molecular pathology.

[21]  T. Wheeler,et al.  Correlative evidence that prostate cancer cell-derived caveolin-1 mediates angiogenesis. , 2007, Human pathology.

[22]  C. Liedtke,et al.  Caveolin-1 expression in benign and malignant lesions of the breast , 2007, World journal of surgical oncology.

[23]  Y. Fujii,et al.  The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. , 2007, Oncology reports.

[24]  M. Nowicki,et al.  Immunocytochemical and biochemical detection of EMMPRIN in the rat tooth germ: differentiation-dependent co-expression with MMPs and co-localization with caveolin-1 in membrane rafts of dental epithelial cells , 2007, Histochemistry and Cell Biology.

[25]  Yair Lotan,et al.  Caveolin‐1 overexpression is associated with aggressive prostate cancer recurrence , 2007, The Prostate.

[26]  Zhi Chen,et al.  Expression of caveolin‐1 in mucoepidermoid carcinoma of the salivary glands: Correlation with vascular endothelial growth factor, microvessel density, and clinical outcome , 2007, Cancer.

[27]  Robert Clarke,et al.  Caveolin-1 Tyrosine Phosphorylation Enhances Paclitaxel-mediated Cytotoxicity* , 2007, Journal of Biological Chemistry.

[28]  Robin L. Jones,et al.  Caveolin 1 Is Overexpressed and Amplified in a Subset of Basal-like and Metaplastic Breast Carcinomas: A Morphologic, Ultrastructural, Immunohistochemical, and In situ Hybridization Analysis , 2007, Clinical Cancer Research.

[29]  Hyun-Ah Kim,et al.  Expression of caveolin-1 is correlated with Akt-1 in colorectal cancer tissues. , 2006, Experimental and molecular pathology.

[30]  K. Moon,et al.  Expression of caveolin-1 in pleomorphic carcinoma of the lung is correlated with a poor prognosis. , 2005, Anticancer research.

[31]  J. Couet,et al.  Caveolin-1 is down-regulated in human lung carcinoma and acts as a candidate tumor suppressor gene. , 2004, Chest.

[32]  M. Tretiakova,et al.  Caveolin and Thrombospondin Expression During Hepatocellular Carcinogenesis , 2004, The American journal of surgical pathology.

[33]  Shu-Chun Lin,et al.  The biphasic differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis. , 2003, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[34]  A. C. Chinault,et al.  Disruption of the caveolin-1 gene impairs renal calcium reabsorption and leads to hypercalciuria and urolithiasis. , 2003, The American journal of pathology.

[35]  K. Takata,et al.  Immunohistochemical characterization of the intracellular pool of water channel aquaporin-2 in the rat kidney , 2002, Anatomical science international.

[36]  M Dietel,et al.  Caveolin-1 is down-regulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene. , 2001, The American journal of pathology.

[37]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[38]  M. Zhu,et al.  Trp1, a Candidate Protein for the Store-operated Ca2+Influx Mechanism in Salivary Gland Cells* , 2000, The Journal of Biological Chemistry.